07:42:20 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



Treatment.com AI Inc
Symbol TRUE
Shares Issued 38,080,115
Close 2024-04-05 C$ 0.66
Market Cap C$ 25,132,876
Recent Sedar Documents

Treatment.com AI closes shares-for-debt deal

2024-04-05 18:28 ET - News Release

Dr. Essam Hamza reports

TREATMENT.COM AI INC. CLOSES DEBT SETTLEMENT TRANSACTIONS

Treatment.com AI Inc., further to its news release dated March 21, 2024, has closed the debt settlement transaction with certain arm's-length creditors to settle an aggregate of $457,362.85 in debt. The debt relates to outstanding principal and accrued interest on the company's 8 per cent unsecured convertible debentures issued on May 17, 2022.

In settlement of the Debt, the Company has issued an aggregate of 1,143,403 units of the Company (the "Units") at a deemed price of $0.40 per Unit (the "Debt Settlement"), with each Unit comprised of one common share in the capital of the Company (a "Share") and one-half of one Share purchase warrant (each whole warrant a "Warrant"). Each whole Warrant entitles the holder thereof to purchase one additional Share (a "Warrant Share") at a price of $0.60 per Warrant Share for a period of 24 months from the date of issuance.

All securities issued in connection with the Debt Settlement are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.

Further, the Company announces that the Company has engaged Aktiencheck.de AG of Bad Marienberg, Germany ("Aktiencheck") to provide a European marketing awareness program for the Company for a period of two (2) weeks commencing on April 8, 2024, in consideration of a payment of 50,000 euros. Aktiencheck does not currently own any interest, directly or indirectly, in the Company or its securities.

About Treatment.com AI Inc.

Treatment.com AI provides solutions for medical education and clinical information support. The Medical Education Suite (MES) provides case-based clinical decision-making testing, grading and remedial action support for the next generation of healthcare professionals. The goals for MES are to enable better performance for Medical School students in their national exams (including OSCE) and for Schools, to reduce administration and exam creation costs, as well as minimizing valuable time for faculty in administering and grading exams.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.